SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013826
Filing Date
2020-11-13
Accepted
2020-11-13 16:34:11
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrbo-20200930x10q.htm 10-Q 1163451
2 EX-10.1 nrbo-20200930ex101739ca6.htm EX-10.1 41662
3 EX-31.1 nrbo-20200930ex31129ccd5.htm EX-31.1 17153
4 EX-32.1 nrbo-20200930ex321440de6.htm EX-32.1 10977
5 GRAPHIC nrbo-20200930ex101739ca6001.jpg GRAPHIC 3277
  Complete submission text file 0001558370-20-013826.txt   5149385

Data Files

Seq Description Document Type Size
6 EX-101.INS nrbo-20200930.xml EX-101.INS 987142
7 EX-101.SCH nrbo-20200930.xsd EX-101.SCH 44722
8 EX-101.CAL nrbo-20200930_cal.xml EX-101.CAL 35947
9 EX-101.DEF nrbo-20200930_def.xml EX-101.DEF 160613
10 EX-101.LAB nrbo-20200930_lab.xml EX-101.LAB 406612
11 EX-101.PRE nrbo-20200930_pre.xml EX-101.PRE 302604
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 201312015
SIC: 2834 Pharmaceutical Preparations